πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 1,756 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 7319000

Compositions and methods for eliciting immune or anti-infective responses

The Board of Regents of the University of Texas System Β· Granted Tue Jan 15 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 10 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7314911

Prostate hyperplasia therapy

The Board of Regents of the University of Texas System Β· Granted Tue Jan 01 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 27 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7312202

Rationally designed and chemically synthesized promoter for genetic vaccine and gene thera

The Board of Regents of the University of Texas System Β· Granted Tue Dec 25 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 20 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7309792

Dimeric small molecule potentiators of apoptosis

The Board of Regents of the University of Texas System Β· Granted Tue Dec 18 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 13 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7309692

Inhibition of chronic myelogenous leukemic cell growth by liposomal-antisense oligodeoxy-n

The Board of Regents of the University of Texas System Β· Granted Tue Dec 18 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 13 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7306804

HIV-specific T-cell induction

The Board of Regents of the University of Texas System Β· Granted Tue Dec 11 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 06 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7303887

Mule: Mcl-1 ubiquitination ligase E3

The Board of Regents of the University of Texas System Β· Granted Tue Dec 04 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 29 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7291348

Compositions and methods for biodegradable microspheres as carriers of bioactive substance

The Board of Regents of the University of Texas System Β· Granted Tue Nov 06 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 01 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7288369

Replication competent hepatitis C virus and methods of use

The Board of Regents of the University of Texas System Β· Granted Tue Oct 30 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 25 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7288646

USPA2 nucleic acid of Moraxella catarrhalis

The Board of Regents of the University of Texas System Β· Granted Tue Oct 30 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 25 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7285556

Thienopyrimidine-based inhibitors of the src family

The Board of Regents of the University of Texas System Β· Granted Tue Oct 23 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 18 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7271148

Inhibition of cellular proteases

The Board of Regents of the University of Texas System Β· Granted Tue Sep 18 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 13 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7271161

Platinum complexes as antitumor agents in combination with biochemical modulation

The Board of Regents of the University of Texas System Β· Granted Tue Sep 18 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 13 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7261875

Dendritic poly (amino acid) carriers and methods of use

The Board of Regents of the University of Texas System Β· Granted Tue Aug 28 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 23 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7256047

Measurement of gluconeogenesis and intermediary metabolism using stable isotopes

The Board of Regents of the University of Texas System Β· Granted Tue Aug 14 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 09 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7252989

Adenovirus supervector system

The Board of Regents of the University of Texas System Β· Granted Tue Aug 07 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 02 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7247316

Compositions and methods for treating lymphoma

The Board of Regents of the University of Texas System Β· Granted Tue Jul 24 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 19 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7247303

Selected antibody CDRs for binding to aminophospholipids

The Board of Regents of the University of Texas System Β· Granted Tue Jul 24 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 19 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7244617

Diminishing viral gene expression by promoter replacement

The Board of Regents of the University of Texas System Β· Granted Tue Jul 17 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 12 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7244760

Methods for preparation and use of psorospermin analogs

The Board of Regents of the University of Texas System Β· Granted Tue Jul 17 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 12 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7244450

Compositions and methods for treating lymphoma

The Board of Regents of the University of Texas System Β· Granted Tue Jul 17 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 12 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7238366

Submicron liposome suspensions obtained from preliposome lyophilizates

The Board of Regents of the University of Texas System Β· Granted Tue Jul 03 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 28 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7229604

Ethylenedicysteine (EC)-drug conjugates, compositions and methods for tissue specific dise

The Board of Regents of the University of Texas System Β· Granted Tue Jun 12 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 07 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7223388

Modified reoviral therapy

The Board of Regents of the University of Texas System Β· Granted Tue May 29 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 24 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted